BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 19, 2018
View Archived Issues
Administration of erlotinib via soaked intraocular lenses prevents posterior capsule opacification
Read More
Actuate begins phase I/II trial of GSK-3beta inhibitor 9-ING-41 in advanced cancers
Read More
CDK7 inhibitor THZ-1 induces breast cancer-specific cell death by suppressing LIN9 expression
Read More
Targeting NKILA in CTLs as a promising new breast cancer immunotherapy strategy
Read More
Irisin and bone: good but complicated
Read More
Premature birth complication prevented by targeting microglia
Read More
FAAH inhibitor PF-04457845 ameliorates stress- and fear-related behavior in humans
Read More
HP-3070 is efficacious and safe for the treatment of schizophrenia in adults
Read More
Selatogrel significantly inhibits platelet aggregation in phase II studies
Read More
Pyramid Biosciences licenses TRK modulator from AstraZeneca
Read More
TK-90 shows promise for prevention of mucositis in clinical study
Read More
Corbus initiates phase III DETERMINE study based on phase II data in dermatomyositis
Read More
Positive phase II data presented in third proof-of-concept study of VX-150
Read More
First patient enrolled in pivotal phase III AGENT study of arfolitixorin
Read More
Topline data presented from phase Ia study of LX-9211
Read More
Spiral Therapeutics initiates phase I trial of new hearing loss drug, LPT-99
Read More
Eli Lilly patents OGA inhibitors
Read More
Myelin needs just the right amount of neighborliness
Read More
Enanta Pharmaceuticals divulges MAP3K5 inhibitors
Read More
DuoHexaBody-CD37 induces potent CDC in ex vivo B-cell lymphoma and leukemia patient samples
Read More
Abide Therapeutics identifies MGL inhibitors
Read More
CD45-AM ADC as promising new approach for safer conditioning prior to bone marrow transplant
Read More
Oxford University Innovation discovers beta-lactamase inhibitors as antibacterials
Read More
Taisho Pharmaceutical describes bacterial LpxC inhibitors
Read More
Phase III study of satralizumab in neuromyelitis optica spectrum disorder meets primary endpoint
Read More
Repigmentation therapy with Scenesse and NB-UVB effective in vitiligo
Read More
DMC recommends stopping phase III study of lumateperone for futility
Read More
Lilly signs collaboration and license agreement for Aduro's cGAS-STING pathway inhibitor program
Read More
PeptiDream and Nihon Medi-Physics enter peptide-radioisotope conjugate alliance
Read More
European Commission approves Dengvaxia for prevention of dengue
Read More